# ERO1A

## Overview
The ERO1A gene encodes the enzyme endoplasmic reticulum oxidoreductase 1 alpha (ERO1α), a thiol oxidoreductase that plays a pivotal role in the oxidative protein folding process within the endoplasmic reticulum (ER) of eukaryotic cells. This enzyme is essential for the formation of disulfide bonds in nascent polypeptides, thereby ensuring proper protein folding and stability. ERO1α functions by facilitating electron transfer through protein disulfide isomerase (PDI), with oxygen acting as the final electron acceptor, and utilizes flavin adenine dinucleotide (FAD) as a coenzyme. The activity of ERO1α is crucial for maintaining ER function, regulating oxidative stress, and modulating ER stress responses, which are vital for various cellular processes, including immune function and calcium signaling. Dysregulation of ERO1A expression is associated with several diseases, particularly cancer, where it is linked to tumor progression and poor prognosis (Shergalis2020Role).

## Structure


## Function
The ERO1A gene encodes the enzyme ERO1α, a thiol oxidoreductase located in the endoplasmic reticulum (ER) of cells. ERO1α plays a crucial role in oxidative protein folding by catalyzing the formation of disulfide bonds in nascent polypeptides, a process essential for proper protein folding and stability. This enzyme facilitates electron transfer through protein disulfide isomerase (PDI), with oxygen serving as the final electron acceptor, and uses flavin adenine dinucleotide (FAD) as a coenzyme for electron transfer (Shergalis2020Role).

ERO1α is involved in maintaining ER function by ensuring the correct folding of proteins, which is vital for the secretion of various proteins, including hormones like insulin and adiponectin. Its activity is linked to the regulation of oxidative stress and ER stress responses, playing a role in the immune system and influencing calcium signaling within the ER (Shergalis2020Role).

The enzyme's activity is tightly regulated to prevent excessive production of hydrogen peroxide (H2O2), which could lead to oxidative stress and cell death. In healthy cells, the generation of H2O2 is controlled, and it is quickly reduced by glutathione peroxidase 8 (GPX8) (Shergalis2020Role).

## Clinical Significance
Alterations in the expression of the ERO1A gene are associated with various diseases, particularly cancer. Overexpression of ERO1A is linked to poor prognosis in several cancers, including cervical, gastric, breast, lung, hepatocellular, and multiple myeloma. In these cancers, high ERO1A expression correlates with reduced survival and disease progression, often associated with higher tumor stages and grades (Shergalis2020Role). ERO1A promotes tumor growth and inhibits T cell response, indicating its role in immuno-oncology (Shergalis2020Role). In pancreatic cancer, ERO1A enhances tumor growth by promoting aerobic glycolysis, and its high expression is associated with worse prognosis (Chen2023A).

ERO1A is also involved in oxidative protein folding, and its dysfunction can lead to diseases related to oxidative stress and endoplasmic reticulum malfunction. In diabetes, ERO1A impacts insulin folding and secretion, with its malfunction potentially leading to the disease. Overexpression of ERO1A is linked to decreased misfolding of mutant proinsulin and reduced ER stress, which is relevant in diabetes models (Shergalis2020Role).

In the context of cancer, ERO1A is implicated in epithelial-to-mesenchymal transition (EMT), promoting this process in several cancers, including cervical cancer (Shergalis2020Role). ERO1A's role in reactive oxygen species (ROS) production also contributes to cellular damage and disease progression, highlighting its potential as a therapeutic target (Shergalis2020Role).

## Interactions
ERO1A, also known as endoplasmic reticulum oxidoreductase 1 alpha, is involved in several critical protein interactions within the endoplasmic reticulum (ER). It primarily interacts with protein disulfide isomerase (PDI), facilitating the formation of disulfide bonds essential for oxidative protein folding. This interaction is mediated through thiol-disulfide exchange reactions, with ERO1A forming mixed disulfides with PDI. The redox state of PDI influences its affinity for ERO1A, with reduced PDI having a higher affinity, allowing it to be re-oxidized by ERO1A (AppenzellerHerzog2008A; Shergalis2020Role; Chen2024Biological).

ERO1A also interacts with other PDI family members, such as ERp44, ERp57, and ERp72, suggesting a broader network of interactions within the ER. These interactions are crucial for maintaining ER redox homeostasis and preventing cellular hyperoxidation (AppenzellerHerzog2008A; Shergalis2020Role). The interaction with ERp44, for instance, can regulate the ERO1A-PDIA1 complex formation and is involved in calcium flux regulation (Shergalis2020Role).

ERO1A's activity is regulated by a disulfide switch mechanism involving the formation of a disulfide bond between Cys 94 and Cys 131, which can silence its function. This regulation is part of a feedback loop where the availability of reduced PDI influences ERO1A activation (AppenzellerHerzog2008A).


## References


[1. (Chen2024Biological) Peng Chen, Amit Sharma, Hans Weiher, and Ingo G.H. Schmidt-Wolf. Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ero1α) in human cancer. Journal of Experimental &amp; Clinical Cancer Research, March 2024. URL: http://dx.doi.org/10.1186/s13046-024-02990-4, doi:10.1186/s13046-024-02990-4. This article has 1 citations.](https://doi.org/10.1186/s13046-024-02990-4)

[2. (AppenzellerHerzog2008A) Christian Appenzeller-Herzog, Jan Riemer, Brian Christensen, Esben S Sørensen, and Lars Ellgaard. A novel disulphide switch mechanism in ero1α balances er oxidation in human cells. The EMBO Journal, 27(22):2977–2987, October 2008. URL: http://dx.doi.org/10.1038/emboj.2008.202, doi:10.1038/emboj.2008.202. This article has 157 citations.](https://doi.org/10.1038/emboj.2008.202)

[3. (Shergalis2020Role) Andrea G. Shergalis, Shuai Hu, Armand Bankhead, and Nouri Neamati. Role of the ero1-pdi interaction in oxidative protein folding and disease. Pharmacology &amp; Therapeutics, 210:107525, June 2020. URL: http://dx.doi.org/10.1016/j.pharmthera.2020.107525, doi:10.1016/j.pharmthera.2020.107525. This article has 86 citations.](https://doi.org/10.1016/j.pharmthera.2020.107525)

[4. (Chen2023A) Haofei Chen, Ning Xu, Jia Xu, Cheng Zhang, Xin Li, Hao Xu, Weixiong Zhu, Jinze Li, Daoming Liang, and Wence Zhou. A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer. Frontiers in Molecular Biosciences, November 2023. URL: http://dx.doi.org/10.3389/fmolb.2023.1298077, doi:10.3389/fmolb.2023.1298077. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2023.1298077)